Asia Pacific Organoids Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Stomach, Intestine, Liver, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology, Disease Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), and Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells)
The Asia Pacific organoids market is expected to grow from US$ 419.14 million in 2023 to US$ 1,207.66 million by 2028. It is estimated to record a CAGR of 23.6% from 2023 to 2028.
Combining Organoid with Organ-On-A-Chip to Fuel Asia Pacific Organoids Market During Forecast Period
Organoid and organ-on-a-chip, which serve as evolving and relevant pathological and human physiological in vitro models, have the potential to revolutionize the conventional paradigm of cancer research and produce real clinical benefits. The recent inclination in the collaborative application of organoids with organ-on-a-chip and 3D bioprinting enables the development of sophisticated cancer models to study underlying mechanisms of tumor-stroma interactions, multiorgan tumor metastasis, and cancer-microenvironment interactions. By incorporating multiple organoids into organ-on-a-chip, organoid-on-a-chip can inherit benefits of both organoid and organ-on-a-chip and provide a valuable tool to study multiorgan tumor metastases and cancer-microenvironment interactions.
In addition, technological advancements will facilitate various applications in biological and biomedical fields for disease modeling and clinical drug screening by combining organoids with organ-on-a-chip. Technological advancements have enabled the development of brain organoids-on-chip, liver organoids-on-chip, intestine organoids-on-chip, etc. Although organoid-on-a-chip is currently a developing field, there is potential for improvement. Hence, there is an increased requirement for cooperative efforts from interdisciplinary researchers to reach organoids' full utility in human biomedical studies. Thus, all these factors are expected to support the market growth in the coming years.
Asia Pacific Organoids Market Overview
The Asia Pacific organoids market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. The market in the region is likely to continue growing at the fastest rate during the forecast period owing to factors such as increasing incidences of cancer, growing demand for gene mutation and cancer research, government efforts to raise awareness related to human organoids, supportive regulations for the development and commercialization of advanced human organoids products, and increased funding for organoids research.
Asia Pacific Organoids Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Organoids Market Segmentation
The Asia Pacific organoids market is segmented on the basis of type, application, source, and country.
Based on type, the market is segmented into stomach, intestine, liver, pancreas, lung, brain, kidney, and others. The intestine segment registered the largest market share in 2023.
Based on application, the Asia Pacific organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held the largest market share in 2023.
Based on source, the Asia Pacific organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment held a larger market share in 2023.
Based on country, the Asia Pacific organoids market is segmented into Japan, China, India, South Korea, Australia, and the Rest of Asia Pacific. Japan dominated the market share in 2023.
Corning Inc; Merck kGaA; PeproTech, Inc; STEMCELL Technologies Inc; and Thermo Fisher Scientific Inc are the leading companies operating in the organoids market in Asia Pacific.
Combining Organoid with Organ-On-A-Chip to Fuel Asia Pacific Organoids Market During Forecast Period
Organoid and organ-on-a-chip, which serve as evolving and relevant pathological and human physiological in vitro models, have the potential to revolutionize the conventional paradigm of cancer research and produce real clinical benefits. The recent inclination in the collaborative application of organoids with organ-on-a-chip and 3D bioprinting enables the development of sophisticated cancer models to study underlying mechanisms of tumor-stroma interactions, multiorgan tumor metastasis, and cancer-microenvironment interactions. By incorporating multiple organoids into organ-on-a-chip, organoid-on-a-chip can inherit benefits of both organoid and organ-on-a-chip and provide a valuable tool to study multiorgan tumor metastases and cancer-microenvironment interactions.
In addition, technological advancements will facilitate various applications in biological and biomedical fields for disease modeling and clinical drug screening by combining organoids with organ-on-a-chip. Technological advancements have enabled the development of brain organoids-on-chip, liver organoids-on-chip, intestine organoids-on-chip, etc. Although organoid-on-a-chip is currently a developing field, there is potential for improvement. Hence, there is an increased requirement for cooperative efforts from interdisciplinary researchers to reach organoids' full utility in human biomedical studies. Thus, all these factors are expected to support the market growth in the coming years.
Asia Pacific Organoids Market Overview
The Asia Pacific organoids market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. The market in the region is likely to continue growing at the fastest rate during the forecast period owing to factors such as increasing incidences of cancer, growing demand for gene mutation and cancer research, government efforts to raise awareness related to human organoids, supportive regulations for the development and commercialization of advanced human organoids products, and increased funding for organoids research.
Asia Pacific Organoids Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Organoids Market Segmentation
The Asia Pacific organoids market is segmented on the basis of type, application, source, and country.
Based on type, the market is segmented into stomach, intestine, liver, pancreas, lung, brain, kidney, and others. The intestine segment registered the largest market share in 2023.
Based on application, the Asia Pacific organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held the largest market share in 2023.
Based on source, the Asia Pacific organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment held a larger market share in 2023.
Based on country, the Asia Pacific organoids market is segmented into Japan, China, India, South Korea, Australia, and the Rest of Asia Pacific. Japan dominated the market share in 2023.
Corning Inc; Merck kGaA; PeproTech, Inc; STEMCELL Technologies Inc; and Thermo Fisher Scientific Inc are the leading companies operating in the organoids market in Asia Pacific.
1. INTRODUCTION
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Organoids Market – by Type
1.3.2 Asia Pacific Organoids Market – by Application
1.3.3 Asia Pacific Organoids Market – by Source
1.3.4 Asia Pacific Organoids Market – by Country
2. ASIA PACIFIC ORGANOIDS MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. ASIA PACIFIC ORGANOIDS MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 Asia Pacific PEST Analysis
4.3 Expert’s Opinion
5. ASIA PACIFIC ORGANOIDS MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increasing Demand for Tumor Modeling and Biobanking
5.1.2 Growing Adoption of Personalized Drugs
5.1.3 Rising Focus on Developing Alternatives for Animal Testing Models
5.2 Market Restraints
5.2.1 Issues Related to Incorporation of Organoids into Existing Workflows
5.2.2 Dearth of Skilled Professionals
5.3 Market Opportunities
5.3.1 Focus on Drug Discovery Activities
5.4 Future Trends
5.4.1 Combining Organoid with Organ-On-A-Chip
5.5 Impact Analysis
6. ORGANOIDS MARKET – ASIA PACIFIC ANALYSIS
6.1 Asia Pacific Organoids Market Revenue Forecast and Analysis
7. ASIA PACIFIC ORGANOIDS MARKET – REVENUE AND FORECAST TO 2028 – BY TYPE
7.1 Overview
7.2 Asia Pacific Organoids Market Revenue Share, by Type (2022 and 2028)
7.3 Stomach
7.3.1 Overview
7.3.2 Stomach: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Intestine
7.4.1 Overview
7.4.2 Intestine: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Liver
7.5.1 Overview
7.5.2 Liver: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Pancreas
7.6.1 Overview
7.6.2 Pancreas: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Lung
7.7.1 Overview
7.7.2 Lung: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Brain
7.8.1 Overview
7.8.2 Brain: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Kidney
7.9.1 Overview
7.9.2 Kidney: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.10 Others
7.10.1 Overview
7.10.2 Others: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8. ASIA PACIFIC ORGANOIDS MARKET – REVENUE AND FORECAST TO 2028 – BY APPLICATION
8.1 Overview
8.2 Asia Pacific Organoids Market Revenue Share, by Application (2022 and 2028)
8.3 Developmental Biology
8.3.1 Overview
8.3.2 Developmental Biology: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Disease Pathology of Infectious Disease
8.4.1 Overview
8.4.2 Disease Pathology of Infectious Disease: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Regenerative Medicine
8.5.1 Overview
8.5.2 Regenerative Medicine: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Drug Toxicity and Efficacy Testing
8.6.1 Overview
8.6.2 Drug Toxicity and Efficacy Testing: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Drug Discovery and Personalized Medicine
8.7.1 Overview
8.7.2 Drug Discovery and Personalized Medicine: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
9. ASIA PACIFIC ORGANOIDS MARKET – REVENUE AND FORECAST TO 2028 – BY SOURCE
9.1 Overview
9.2 Asia Pacific Organoids Market Revenue Share, by Source (2022and 2028)
9.3 Pluripotent Stem Cells
9.3.1 Overview
9.3.2 Pluripotent Stem Cells: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Organ-specific Adult Stem Cells
9.4.1 Overview
9.4.2 Organ-specific Adult Stem Cells: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10. ASIA PACIFIC ORGANOIDS MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
10.1 Asia Pacific Organoids Market
10.1.1 Overview
10.1.2 Asia Pacific Organoids Market, by Country, 2022 & 2028 (%)
10.1.2.1 China: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 China: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.3 China: Asia Pacific Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.1.4 China: Asia Pacific Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.1.5 China: Asia Pacific Organoids Market, by Source 2020-2028 (US$ Million)
10.1.2.2 Japan: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Japan: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.3 Japan: Asia Pacific Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.2.4 Japan: Asia Pacific Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.2.5 Japan: Asia Pacific Organoids Market, by Source 2020-2028 (US$ Million)
10.1.2.3 India: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 India: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3 India: Asia Pacific Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.3.4 India: Asia Pacific Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.3.5 India: Asia Pacific Organoids Market, by Source 2020-2028 (US$ Million)
10.1.2.4 South Korea: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.1 Overview
10.1.2.4.2 South Korea: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.3 South Korea: Asia Pacific Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.4.4 South Korea: Asia Pacific Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.4.5 South Korea: Asia Pacific Organoids Market, by Source 2020-2028 (US$ Million)
10.1.2.5 Australia: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.5.1 Overview
10.1.2.5.2 Australia: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.5.3 Australia: Asia Pacific Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.5.4 Australia Asia Pacific Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
10.1.2.5.5 Australia: Asia Pacific Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.5.6 Australia: Asia Pacific Organoids Market, by Source 2020-2028 (US$ Million)
10.1.2.6 Rest of Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.6.3 Rest of Asia Pacific Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.6.4 Rest of Asia Pacific Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.6.5 Rest of Asia Pacific Organoids Market, by Source 2020-2028 (US$ Million)
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. COMPANY PROFILES
12.1 STEMCELL Technologies Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 PeproTech, Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Thermo Fisher Scientific Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Corning Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Merck KGaA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Organoids Market – by Type
1.3.2 Asia Pacific Organoids Market – by Application
1.3.3 Asia Pacific Organoids Market – by Source
1.3.4 Asia Pacific Organoids Market – by Country
2. ASIA PACIFIC ORGANOIDS MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. ASIA PACIFIC ORGANOIDS MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 Asia Pacific PEST Analysis
4.3 Expert’s Opinion
5. ASIA PACIFIC ORGANOIDS MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increasing Demand for Tumor Modeling and Biobanking
5.1.2 Growing Adoption of Personalized Drugs
5.1.3 Rising Focus on Developing Alternatives for Animal Testing Models
5.2 Market Restraints
5.2.1 Issues Related to Incorporation of Organoids into Existing Workflows
5.2.2 Dearth of Skilled Professionals
5.3 Market Opportunities
5.3.1 Focus on Drug Discovery Activities
5.4 Future Trends
5.4.1 Combining Organoid with Organ-On-A-Chip
5.5 Impact Analysis
6. ORGANOIDS MARKET – ASIA PACIFIC ANALYSIS
6.1 Asia Pacific Organoids Market Revenue Forecast and Analysis
7. ASIA PACIFIC ORGANOIDS MARKET – REVENUE AND FORECAST TO 2028 – BY TYPE
7.1 Overview
7.2 Asia Pacific Organoids Market Revenue Share, by Type (2022 and 2028)
7.3 Stomach
7.3.1 Overview
7.3.2 Stomach: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Intestine
7.4.1 Overview
7.4.2 Intestine: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Liver
7.5.1 Overview
7.5.2 Liver: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Pancreas
7.6.1 Overview
7.6.2 Pancreas: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Lung
7.7.1 Overview
7.7.2 Lung: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Brain
7.8.1 Overview
7.8.2 Brain: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Kidney
7.9.1 Overview
7.9.2 Kidney: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.10 Others
7.10.1 Overview
7.10.2 Others: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8. ASIA PACIFIC ORGANOIDS MARKET – REVENUE AND FORECAST TO 2028 – BY APPLICATION
8.1 Overview
8.2 Asia Pacific Organoids Market Revenue Share, by Application (2022 and 2028)
8.3 Developmental Biology
8.3.1 Overview
8.3.2 Developmental Biology: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Disease Pathology of Infectious Disease
8.4.1 Overview
8.4.2 Disease Pathology of Infectious Disease: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Regenerative Medicine
8.5.1 Overview
8.5.2 Regenerative Medicine: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Drug Toxicity and Efficacy Testing
8.6.1 Overview
8.6.2 Drug Toxicity and Efficacy Testing: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Drug Discovery and Personalized Medicine
8.7.1 Overview
8.7.2 Drug Discovery and Personalized Medicine: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
9. ASIA PACIFIC ORGANOIDS MARKET – REVENUE AND FORECAST TO 2028 – BY SOURCE
9.1 Overview
9.2 Asia Pacific Organoids Market Revenue Share, by Source (2022and 2028)
9.3 Pluripotent Stem Cells
9.3.1 Overview
9.3.2 Pluripotent Stem Cells: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Organ-specific Adult Stem Cells
9.4.1 Overview
9.4.2 Organ-specific Adult Stem Cells: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10. ASIA PACIFIC ORGANOIDS MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
10.1 Asia Pacific Organoids Market
10.1.1 Overview
10.1.2 Asia Pacific Organoids Market, by Country, 2022 & 2028 (%)
10.1.2.1 China: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 China: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.3 China: Asia Pacific Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.1.4 China: Asia Pacific Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.1.5 China: Asia Pacific Organoids Market, by Source 2020-2028 (US$ Million)
10.1.2.2 Japan: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Japan: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.3 Japan: Asia Pacific Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.2.4 Japan: Asia Pacific Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.2.5 Japan: Asia Pacific Organoids Market, by Source 2020-2028 (US$ Million)
10.1.2.3 India: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 India: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3 India: Asia Pacific Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.3.4 India: Asia Pacific Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.3.5 India: Asia Pacific Organoids Market, by Source 2020-2028 (US$ Million)
10.1.2.4 South Korea: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.1 Overview
10.1.2.4.2 South Korea: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.3 South Korea: Asia Pacific Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.4.4 South Korea: Asia Pacific Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.4.5 South Korea: Asia Pacific Organoids Market, by Source 2020-2028 (US$ Million)
10.1.2.5 Australia: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.5.1 Overview
10.1.2.5.2 Australia: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.5.3 Australia: Asia Pacific Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.5.4 Australia Asia Pacific Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
10.1.2.5.5 Australia: Asia Pacific Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.5.6 Australia: Asia Pacific Organoids Market, by Source 2020-2028 (US$ Million)
10.1.2.6 Rest of Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.6.3 Rest of Asia Pacific Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.6.4 Rest of Asia Pacific Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.6.5 Rest of Asia Pacific Organoids Market, by Source 2020-2028 (US$ Million)
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. COMPANY PROFILES
12.1 STEMCELL Technologies Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 PeproTech, Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Thermo Fisher Scientific Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Corning Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Merck KGaA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. China Asia Pacific Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. China Asia Pacific Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 3. China Asia Pacific Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 4. Japan Asia Pacific Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 5. Japan Asia Pacific Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 6. Japan Asia Pacific Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 7. India Asia Pacific Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. India Asia Pacific Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 9. India Asia Pacific Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 10. South Korea Asia Pacific Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. South Korea Asia Pacific Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 12. South Korea Asia Pacific Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 13. Australia Asia Pacific Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 14. Australia Asia Pacific Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 15. Rest of Asia Pacific Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of Asia Pacific Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Asia Pacific Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 18. Organic Developments Done by Companies
Table 19. Inorganic Developments Done by Companies
Table 20. Glossary of Terms
Table 1. China Asia Pacific Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. China Asia Pacific Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 3. China Asia Pacific Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 4. Japan Asia Pacific Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 5. Japan Asia Pacific Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 6. Japan Asia Pacific Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 7. India Asia Pacific Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. India Asia Pacific Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 9. India Asia Pacific Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 10. South Korea Asia Pacific Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. South Korea Asia Pacific Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 12. South Korea Asia Pacific Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 13. Australia Asia Pacific Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 14. Australia Asia Pacific Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 15. Rest of Asia Pacific Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of Asia Pacific Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Asia Pacific Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 18. Organic Developments Done by Companies
Table 19. Inorganic Developments Done by Companies
Table 20. Glossary of Terms
LIST OF FIGURES
Figure 1. Asia Pacific Organoids Market Segmentation
Figure 2. Asia Pacific Organoids Market by Region
Figure 3. Asia Pacific Organoids Market Overview
Figure 4. Intestine is The Largest Share of Type Segment in Asia Pacific Organoids Market
Figure 5. Japan Expected to Show Remarkable Growth During Forecast Period
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Asia Pacific Experts’ Opinion
Figure 8. Asia Pacific Organoids Market Impact Analysis of Drivers and Restraints
Figure 9. Asia Pacific Organoids Market – Revenue Forecast and Analysis – 2020–2028
Figure 10. Asia Pacific Organoids Market Revenue Share, by Type (2022 and 2028)
Figure 11. Stomach: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Intestine: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Liver: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Pancreas: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Lung: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Brain: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Kidney: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Others: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Asia Pacific Organoids Market Revenue Share, by Application (2022 and 2028)
Figure 20. Developmental Biology: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Disease Pathology of Infectious Disease: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Regenerative Medicine: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Drug Toxicity and Efficacy Testing: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Drug Discovery and Personalized Medicine: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Others: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Asia Pacific Organoids Market Revenue Share, by Source (2022 and 2028)
Figure 27. Pluripotent Stem Cells: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Organ-specific Adult Stem Cells: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Asia Pacific Organoids Market, by Key Country – Revenue (2022) (US$ Million)
Figure 30. Asia Pacific Organoids Market, by Country, 2022 & 2028 (%)
Figure 31. China: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Japan: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. India: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. South Korea: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Australia: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Rest of Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Growth Strategies Done by the Companies in the Market, (%)
Figure 1. Asia Pacific Organoids Market Segmentation
Figure 2. Asia Pacific Organoids Market by Region
Figure 3. Asia Pacific Organoids Market Overview
Figure 4. Intestine is The Largest Share of Type Segment in Asia Pacific Organoids Market
Figure 5. Japan Expected to Show Remarkable Growth During Forecast Period
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Asia Pacific Experts’ Opinion
Figure 8. Asia Pacific Organoids Market Impact Analysis of Drivers and Restraints
Figure 9. Asia Pacific Organoids Market – Revenue Forecast and Analysis – 2020–2028
Figure 10. Asia Pacific Organoids Market Revenue Share, by Type (2022 and 2028)
Figure 11. Stomach: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Intestine: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Liver: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Pancreas: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Lung: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Brain: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Kidney: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Others: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Asia Pacific Organoids Market Revenue Share, by Application (2022 and 2028)
Figure 20. Developmental Biology: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Disease Pathology of Infectious Disease: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Regenerative Medicine: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Drug Toxicity and Efficacy Testing: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Drug Discovery and Personalized Medicine: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Others: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Asia Pacific Organoids Market Revenue Share, by Source (2022 and 2028)
Figure 27. Pluripotent Stem Cells: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Organ-specific Adult Stem Cells: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Asia Pacific Organoids Market, by Key Country – Revenue (2022) (US$ Million)
Figure 30. Asia Pacific Organoids Market, by Country, 2022 & 2028 (%)
Figure 31. China: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Japan: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. India: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. South Korea: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Australia: Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Rest of Asia Pacific Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Growth Strategies Done by the Companies in the Market, (%)
